These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12507837)

  • 1. Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral)+metronidazole (intravenous/oral) with ceftriaxone (intravenous)+metronidazole (intravenous/oral) for the treatment of intra-abdominal infections.
    Starakis I; Karravias D; Asimakopoulos C; Kolaras P; Nikolaidis P; Harlaftis N; Skoutelis A; Bassaris H
    Int J Antimicrob Agents; 2003 Jan; 21(1):49-57. PubMed ID: 12507837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections.
    Wacha H; Warren B; Bassaris H; Nikolaidis P;
    Surg Infect (Larchmt); 2006 Aug; 7(4):341-54. PubMed ID: 16978077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).
    Weiss G; Reimnitz P; Hampel B; Muehlhofer E; Lippert H;
    J Chemother; 2009 Apr; 21(2):170-80. PubMed ID: 19423470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
    Yellin AE; Hassett JM; Fernandez A; Geib J; Adeyi B; Woods GL; Teppler H;
    Int J Antimicrob Agents; 2002 Sep; 20(3):165-73. PubMed ID: 12385694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections.
    Paladino JA; Gilliland-Johnson KK; Adelman MH; Cohn SM
    Surg Infect (Larchmt); 2008 Jun; 9(3):325-33. PubMed ID: 18570574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan.
    Mikamo H; Matsumizu M; Nakazuru Y; Nagashima M
    J Infect Chemother; 2015 Feb; 21(2):96-104. PubMed ID: 25442806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
    Solomkin JS; Reinhart HH; Dellinger EP; Bohnen JM; Rotstein OD; Vogel SB; Simms HH; Hill CS; Bjornson HS; Haverstock DC; Coulter HO; Echols RM
    Ann Surg; 1996 Mar; 223(3):303-15. PubMed ID: 8604912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oral antimicrobials for the management of intra-abdominal infections.
    Solomkin JS; Dellinger EP; Bohnen JM; Rostein OD
    New Horiz; 1998 May; 6(2 Suppl):S46-52. PubMed ID: 9654311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.
    Solomkin J; Zhao YP; Ma EL; Chen MJ; Hampel B;
    Int J Antimicrob Agents; 2009 Nov; 34(5):439-45. PubMed ID: 19692210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections.
    Cohn SM; Lipsett PA; Buchman TG; Cheadle WG; Milsom JW; O'Marro S; Yellin AE; Jungerwirth S; Rochefort EV; Haverstock DC; Kowalsky SF
    Ann Surg; 2000 Aug; 232(2):254-62. PubMed ID: 10903605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
    Walters DJ; Solomkin JS; Paladino JA
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
    Madan AK
    Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.
    Khan S; Gupta DK; Khan DN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
    Maltezou HC; Nikolaidis P; Lebesii E; Dimitriou L; Androulakakis E; Kafetzis DA
    Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):643-6. PubMed ID: 11714046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
    Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin vs. cefotaxime regimens for the treatment of intra-abdominal infections.
    Hoogkamp-Korstanje JA
    Infection; 1995; 23(5):278-82. PubMed ID: 8557385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
    Solomkin J; Hershberger E; Miller B; Popejoy M; Friedland I; Steenbergen J; Yoon M; Collins S; Yuan G; Barie PS; Eckmann C
    Clin Infect Dis; 2015 May; 60(10):1462-71. PubMed ID: 25670823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
    Barie PS; Vogel SB; Dellinger EP; Rotstein OD; Solomkin JS; Yang JY; Baumgartner TF
    Arch Surg; 1997 Dec; 132(12):1294-302. PubMed ID: 9403533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised prospective controlled study of ciprofloxacin with metronidazole versus amoxicillin/clavulanic acid with metronidazole in the treatment of intra-abdominal infection.
    Yoshioka K; Youngs DJ; Keighley MR
    Infection; 1991; 19(1):25-9. PubMed ID: 2013505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.